Rekha Hemrajani

Companies

• LB PHARMACEUTICALS INCBoard member Sep 10, 2025 to now¹
• BioAge Labs, Inc.Board member Sep 25, 2024 to now²
• MaxCyte (United States)Board member Jul 29, 2021 to now³
• ALX ONCOLOGY HOLDINGS INCBoard member Jul 16, 2020 to now⁴
• Jiya Acquisition Corp.Board member Nov 18, 2020 to Nov 18, 2020⁵
• Jiya Acquisition Corp.Chief executive officer Nov 18, 2020 to Nov 18, 2020⁵
• Avalanche BiotechnologiesBoard member May 3, 2019 to Jun 25, 2020⁶
• Aravive, Inc.Board member Jan 9, 2020 to Jan 9, 2020⁷
• Aravive, Inc.Chief executive officer Jan 9, 2020 to Jan 9, 2020⁷
• Aravive, Inc.President Jan 9, 2020 to Jan 9, 2020⁷
• Arcus BiosciencesOfficer Mar 25, 2019 to Mar 25, 2019⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MUMaxCyte (United States) MXCT70,314 shares⁹$91.4K at $1.30Jun 17, 2026
• AOALX ONCOLOGY HOLDINGS INC ALXO33,000 shares¹⁰$31.4K at $0.95Dec 2, 2024
• BLBioAge Labs, Inc. BIOA3,000 shares¹¹$14.8K at $4.95Sep 27, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 17, 2026Granted 30,421 shares of MaxCyte (United States)⁹
• Jun 25, 2025Sold 10,684 shares at $2.09 of MaxCyte (United States)¹²
• Jun 18, 2025Granted 29,210 shares of MaxCyte (United States)¹³
• Dec 2, 2024Bought 30,000 shares at $1.55 of ALX ONCOLOGY HOLDINGS INC¹⁰
• Sep 27, 2024Bought 3,000 shares at $18.00 of BioAge Labs, Inc.¹¹
• Jun 11, 2024Granted 21,367 shares of MaxCyte (United States)¹⁴